These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37183974)

  • 1. Validation of the Turkish version of the Lewy body composite risk score.
    Mutlay F; Kaya D; Ates Bulut E; Akpınar Söylemez B; Öntan MS; Isık AT
    Appl Neuropsychol Adult; 2023 May; ():1-7. PubMed ID: 37183974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IMPROVING THE CLINICAL DETECTION OF LEWY BODY DEMENTIA WITH THE LEWY BODY COMPOSITE RISK SCORE.
    Galvin JE
    Alzheimers Dement (Amst); 2015 Sep; 1(3):316-324. PubMed ID: 26405688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the Korean Version of the Lewy Body Composite Risk Score (K-LBCRS).
    Ryu HJ; Kim M; Moon Y; Choi Y; Han JY; Galvin JE; Han SH
    J Alzheimers Dis; 2017; 55(4):1395-1401. PubMed ID: 27834773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.
    Yoon JH; Kim M; Moon SY; Yong SW; Hong JM
    J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of the clinical diagnosis of dementia with Lewy bodies (DLB) among the Italian Dementia Centers: a study by the Italian DLB study group (DLB-SINdem).
    Russo M; Carrarini C; Di Iorio A; Pellegrino R; Bruni AC; Caratozzolo S; Chiari A; Pretta S; Marra C; Cotelli MS; Arighi A; Fumagalli GG; Cataruzza T; Caso F; Paci C; Rosso M; Amici S; Giannandrea D; Pilotto A; Luzzi S; Castellano A; D'antonio F; Luca A; Gelosa G; Piccoli T; Mauri M; Agosta F; Babiloni C; Borroni B; Bozzali M; Filippi M; Galimberti D; Monastero R; Muscio C; Parnetti L; Perani D; Serra L; Silani V; Tiraboschi P; Cagnin A; Padovani A; Bonanni L;
    Neurol Sci; 2022 Jul; 43(7):4221-4229. PubMed ID: 35244829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity and reliability of the Turkish version of the ALBA screening instrument for Lewy body dementia in older adults.
    Kaya D; Yesil Gurel BH; Akpinar Soylemez B; Dost FS; Dokuzlar O; Mutlay F; Ates Bulut E; Petek K; Golimstok AB; Isik AT
    Appl Neuropsychol Adult; 2024; 31(6):1457-1462. PubMed ID: 36332080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early differentiation of dementia with Lewy bodies and Alzheimer's disease: Heart rate variability at mild cognitive impairment stage.
    Kim MS; Yoon JH; Hong JM
    Clin Neurophysiol; 2018 Aug; 129(8):1570-1578. PubMed ID: 29883835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of dementia with Lewy bodies (DLB) and mild cognitive impairment using the Lewy body dementia module (LBD-MOD).
    Galvin JE; Chrisphonte S; Cohen I; Greenfield KK; Kleiman MJ; Moore C; Riccio ML; Rosenfeld A; Shkolnik N; Walker M; Chang LC; Tolea MI
    Alzheimers Dement; 2021 Oct; 17(10):1675-1686. PubMed ID: 33793069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prodromal Dementia with Lewy Bodies and Prodromal Alzheimer's Disease: A Comparison of the Cognitive and Clinical Profiles.
    Sadiq D; Whitfield T; Lee L; Stevens T; Costafreda S; Walker Z
    J Alzheimers Dis; 2017; 58(2):463-470. PubMed ID: 28453473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Montreal Cognitive Assessment and Mini-Mental State Examination performance in patients with mild-to-moderate dementia with Lewy bodies, Alzheimer's disease, and normal participants in Taiwan.
    Wang CS; Pai MC; Chen PL; Hou NT; Chien PF; Huang YC
    Int Psychogeriatr; 2013 Nov; 25(11):1839-48. PubMed ID: 23919950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRS in mild cognitive impairment: early differentiation of dementia with Lewy bodies and Alzheimer's disease.
    Zhang B; Ferman TJ; Boeve BF; Smith GE; Maroney-Smith M; Spychalla AJ; Knopman DS; Jack CR; Petersen RC; Kantarci K
    J Neuroimaging; 2015; 25(2):269-274. PubMed ID: 25039916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic Resonance Imaging in Stable Mild Cognitive Impairment, Prodromal Alzheimer's Disease, and Prodromal Dementia with Lewy Bodies.
    Siddiqui TG; Whitfield T; Praharaju SJ; Sadiq D; Kazmi H; Ben-Joseph A; Walker Z
    Dement Geriatr Cogn Disord; 2020; 49(6):583-588. PubMed ID: 33227783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychiatric symptoms and α-Synuclein profile of patients with Parkinson's disease dementia, dementia with Lewy bodies and Alzheimer's disease.
    Bougea A; Stefanis L; Paraskevas GP; Emmanouilidou E; Efthymiopoulou E; Vekrelis K; Kapaki E
    J Neurol; 2018 Oct; 265(10):2295-2301. PubMed ID: 30083953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of the pareidolia test in mild cognitive impairment with Lewy bodies and Alzheimer's disease.
    Hamilton CA; Matthews FE; Allan LM; Barker S; Ciafone J; Donaghy PC; Durcan R; Firbank MJ; Lawley S; O'Brien JT; Roberts G; Taylor JP; Thomas AJ
    Int J Geriatr Psychiatry; 2021 Sep; 36(9):1407-1414. PubMed ID: 33772864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of Conversion from Mild Cognitive Impairment to Dementia with Lewy Bodies: Data from the National Alzheimer's Coordinating Center.
    Payne S; Shofer JB; Shutes-David A; Li G; Jankowski A; Dean P; Tsuang D
    J Alzheimers Dis; 2022; 86(4):1643-1654. PubMed ID: 35213374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High specificity of MMSE pentagon scoring for diagnosis of prodromal dementia with Lewy bodies.
    Cagnin A; Bussè C; Jelcic N; Gnoato F; Mitolo M; Caffarra P
    Parkinsonism Relat Disord; 2015 Mar; 21(3):303-5. PubMed ID: 25547859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood mRNA Expression in Alzheimer's Disease and Dementia With Lewy Bodies.
    Donaghy PC; Cockell SJ; Martin-Ruiz C; Coxhead J; Kane J; Erskine D; Koss D; Taylor JP; Morris CM; O'Brien JT; Thomas AJ
    Am J Geriatr Psychiatry; 2022 Sep; 30(9):964-975. PubMed ID: 35283023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
    Rolinski M; Fox C; Maidment I; McShane R
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of mild cognitive impairment tending to convert into Alzheimer's disease or dementia with Lewy bodies: A follow-up study in a memory clinic.
    Kondo D; Ota K; Kasanuki K; Fujishiro H; Chiba Y; Murayama N; Sato K; Hirayasu Y; Arai H; Iseki E
    J Neurol Sci; 2016 Oct; 369():102-108. PubMed ID: 27653873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term cognitive outcome of Alzheimer's disease and dementia with Lewy bodies: dual disease is worse.
    Blanc F; Mahmoudi R; Jonveaux T; Galmiche J; Chopard G; Cretin B; Demuynck C; Martin-Hunyadi C; Philippi N; Sellal F; Michel JM; Tio G; Stackfleth M; Vandel P; Magnin E; Novella JL; Kaltenbach G; Benetos A; Sauleau EA
    Alzheimers Res Ther; 2017 Jun; 9(1):47. PubMed ID: 28655337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.